As of Feb 22
| -0.01 / -0.06%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 20.00, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +22.17% increase from the last price of 16.37.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.